Specialty Pharmacy

Synjardy, a type 2 diabetes treatment, is now available by prescription in US pharmacies.

High-dose chemotherapy and autologous stem cell transplantation show promise for patients with light-chain amyloidosis.

Processing speed linked to both activity and participation among patients with MS.

Many colon cancer disparities found in patients of different races under 50-years old.

Secukinumab shows promise in the treatment of patients with psoriatic arthritis.

Carcinoid syndrome frequently prevents patients from leading active lives.

RA patients carry myocardial and vascular abnormalities even in the earlier stages of disease progression.

Dinaciclib may be able to eliminate metastases without shrinking the primary tumor.

Recall affects products that were compounded prior to September 1, 2015.

A generic version of Avodart, used to treat the symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate, has been launched by Teva Pharmaceutical Industries Ltd.

Researchers determine why HIV persists in some patients and remains dormant in others.

Jay Greco, RPh, owner of Jersey Shore Pharmacy, discusses significant issues causing difficulties for specialty pharmacy.

Community level factors linked to COPD include rural residence, southern residence, and community poverty.

Treatment with Zinbryta caused reductions in the risk of 24-week confirmed multiple sclerosis disability progression.

Targeted drug delivery focuses on diseased cells to minimize side effects on normal cells.

Study finds ultrasound should be included in the management of RA patients in clinical remission.

Significant decrease found in oral and intestinal microbial diversity during chemotherapy.

Alemtuzumab shows promise in multiple sclerosis patients who received prior disease-modifying therapy.

Arizona Cannabis Nurses Association seeks to expand medical marijuana access for chronic conditions, such as post-traumatic stress disorder.

Legislation will enable seniors in medically underserved communities to access pharmacist patient care services.

HHpgV-1 virus found in serum samples from blood transfusion recipients and hemophilia patients.

Opportunistic infections accounted for nearly one-fourth of all readmissions.

A pharmacy in Kentucky will pay $9.25 million to settle claims that it received money from Abbott for promoting a drug to nursing home patients.

Agreement will send nearly 500 million units of treatment over the course of 5 years to the World Federation of Hemophilia.

Just 5% of myeloma cases are in the first phase at diagnosis.

Families of children with cancer face food, housing, and energy insecurity.

Marc O'Connor, chief operating officer of Curant Health, discusses methods Curant uses to maintain adherence to specialty drug regimens.

Improvements in itching scores maintained from week 16 to week 52 in patients who received Otezla.

Inhibiting growth receptor presents promising treatment option.

HIV patients not on recommended regimens are less likely to achieve viral suppression and more likely to report side effects.